Abstract
Several new antifungal agents are currently in various stages of development. This is promising, as there is a continued need for new agents to treat invasive fungal infections. Which ones will receive approval for clinical use and their impact in patients with these infections remain unknown.
Original language | English (US) |
---|---|
Pages (from-to) | 539-546 |
Number of pages | 8 |
Journal | Current Opinion in Infectious Diseases |
Volume | 28 |
Issue number | 6 |
DOIs | |
State | Published - Nov 3 2015 |
Keywords
- Aspergillus
- Candida
- antifungal resistance
- invasive fungal infections
- investigational antifungals
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases